semaglutide + tirzepatide Troubling Findings in Study of GLP-1 Compounders Popular weight loss drugs could

Neuroprotection : Promising results in animal models of neurodegenerative diseases, with ongoing clinical trials examining potential applications in Alzheimer's disease and Parkinson's disease

Jumpstart Your Weight Loss Journey At Ageless Center, we specialize in helping our patients achieve sustainable weight loss through personalized care and expert guidance

Constipation Why it happens: Slower GI transit

Similarly, people with a history of psychiatric medications were 12% more likely to discontinue treatment within the first year, while those living with cardiovascular disease or other chronic conditions were around 10% more likely to stop treatment early -- also suggesting a higher likelihood of experiencing adverse effects

For instance, semaglutide and liraglutide, two GLP-1RA agonist drugs, have been associated with weight loss and body weight maintenance (1012)

This highlights the potential use of semaglutide due to its low cost and superior performance